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Abstract 
The aim of this study was to compare MRI and histological estimates of the mean 
vessel diameter (mVD), the vessel density (Density), and the vessel size index (VSI) 
obtained in the same tumor-bearing animals.  
Twenty-seven rats bearing intracranial glioma (C6 or RG2) were imaged by MRI. 
Changes in transverse relaxations (R2* and R2) were induced by the injection of an 
iron-based contrast agent and were mapped using a multi gradient-echo spin-echo 
sequence. Then, brain vascular network was studied ex vivo by histology. Three 
regions of interest were drawn in apparently normal tissue (neocortex and striatum) 
and in the tumor. In vivo mVDMRI, DensityMRI, and VSIMRI were measured; ex vivo, 
mVDhisto, Densityhisto, and VSIhisto were quantified on the same animals. 
MRI and histology measurements differed by -15 to 26%. A positive correlation was 
found between MRI and histology for mVD, Density, and VSI counterparts (R²=0.62, 
0.50, 0.73, respectively; p<0.001 in all cases). This study indicates that MRI and 
histology yields well correlated estimates of mVD, Density, and VSI. VSI is the 
closest MRI estimate to histology. As Density and mVD or VSI provide 
complementary information, it is worth computing them to characterize angiogenesis 
beyond blood volume fraction. 
Words: 196/200 
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Introduction 
The assessment of angiogenesis contributes to determining tumor grade and 
prognosis (1-3) for brain tumor suffering patients. In clinical practice, one estimates 
the microvessel density from surgical biopsies (4). This invasive approach yields the 
angiogenic features of a small part of the tumor but remains the only approved 
approach for tumor grading by WHO. In case of a heterogeneous high grade tumor, 
this characterization is not sufficient (5). In vivo imaging of angiogenic features is 
therefore very desirable. 
To characterize angiogenesis in vivo with MRI, one usually maps the blood volume 
fraction (BVf) using a bolus tracking approach (6). On the one hand, BVf increases 
with the number of microvessels within an imaging voxel. On the other hand, BVf 
may remain constant in case of microvessel diameter increase and vessel density 
decrease (7), and thus becomes blind to angiogenic processes. This lack of BVf 
sensitivity to fully characterize angiogenesis is well-known by anatomopathologists 
who rather use the microvessel density (8). From a physical point of view, vessel 
density may be seen as a combination between microvessel diameter and BVf (9). 
Using MRI, one may also image angiogenesis beyond BVf. This involves measuring 
the changes in transverse relaxivities induced by the injection of an intravascular 
contrast agent: changes in R2 (noted R2 and measured using spin-echoes) and in 
R2* (noted R2* and measured using gradient-echoes). Due to the sensitivity of MRI 
to water diffusion (ADC), R2 depends on the vessel diameter while R2* does not 
(10). Three processing approaches have then been proposed. All rely on some 
symplifying assumptions (small BVf, intravoxel microvessels modeled by perfect 
cylinders, statistical analysis of the intravoxel microvessel distribution, signals 
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measured in the static dephasing regime) (9-17). (i) Dennie et al. introduced 
R2*/R2 as a non-quantitative estimate of the mean vessel diameter in the voxel 
(mVDMRI) (11, 12); (ii) Based on (R2)
3/(R2*)
2, Jensen et al. derived an estimate of 
the microvessel density (DensityMRI) (9, 13, 14); (iii) Based on (R2*/R2)
3/2, Tropres 
et al. defined a quantitative index of the distribution of microvessel diameters within 
the voxel, the vessel size index (VSIMRI) (15-17). VSI accounts for the influence of 
ADC on R2. These three methods have been applied in humans (9, 12, 16, 18) and 
a few validation studies have been conducted (7, 11, 13, 17, 19). They have not been 
evaluated together on the same dataset, however. How do they compare to histology 
and which approach should be used to characterize angiogenesis beyond BVf? 
In this study, we compare MRI and histological estimates of the mVD, Density, and 
VSI. For this purpose, we used data collected on rat bearing orthotopic C6 and RG2 
gliomas at four growth stages, two glioma models which present differences in their 
microvasculature (7). Note that the data regarding tumor evolution, including 
observations on angiogenic factors, have already been described in (7). 
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Methods 
Animal manipulations 
The study design was approved by the local committee for animal care and use 
(approval 081). Experiments were performed under permits n° 380508, 
A3851610004 and B3851610003 from the French Ministry of Agriculture. All 
experiments were performed under anesthesia: 5% isoflurane for induction, 2 % for 
maintenance in 70 % air / 30 % oxygen. Rectal temperature was maintained at 
37.0 ± 0.5°C throughout the experiments. 
 
Tumor cell implantation 
Male Wistar (175-200 g, n=15) and Fischer 344 (150-175 g, n=12) rats were used for 
the C6 and RG2 high grade glioma models, respectively. The cell suspension (1.105 
C6 cells (ATCC, CCL-107); 5.103 RG2 cells (ATCC, CRL-223)) was injected in the 
right striatum as described in (20). 
Each animal was imaged once by MRI and euthanized immediately after for 
histology. The C6 model was imaged 11 (n=4), 15 (n=4), 20 (n=4) and 25 days (n=3) 
after tumor implantation and the RG2 model 6 (n=3), 10 (n=4), 14 (n=2) and 18 days 
(n=3) after tumor implantation. In both cases, the last time point corresponds to about 
3 days prior to mean survival time (unpublished data) allowing the development of 
angiogenesis in both cases and thereby the exploration of a large range of 
microvascular characteristics. 
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In vivo MRI experiments 
Experiments were performed on a horizontal 2.35 Tesla (40 cm diameter) magnet 
equipped with actively shielded gradient coils (Magnex Scientific Ltd., Oxford, UK) 
and interfaced to a SMIS console (SMIS Ltd, Guildford, UK). After anesthesia, the tail 
vein was equipped with a catheter. 200 µl of plasma were obtained (plasma “before 
injection”). 
Maps of Apparent Diffusion Coefficient (ADC) of water were computed from 3 
diffusion-weighted spin-echo images (in X, Y, and Z directions) with b = 900 s.mm-2 
and a reference image (b ≈ 0 s.mm-2) (voxel size = 234x454x1000 µm3). A multi 
gradient-echo and spin-echo MRI sequence (TR = 6 s, 7 evenly spaced gradient-
echoes = [6-42] ms, 1 spin-echo = 102 ms, voxel size = 234x454x1000 µm3) was 
acquired just prior to and 4 min after administration of Sinerem® via the tail vein in 
about 20 sec (200 µmoles of iron/kg body weight) (Sinerem®, Guerbet SA, France; 
Combidex®, Advanced Magnetics, Inc, USA). Sinerem® is a dextran coated 
ultrasmall super-paramagnetic iron oxide (USPIO) contrast agent of about 20 nm in 
size and 4.5 hours plasma half-life (17). This USPIO does not significantly 
extravasate in these tumor models within the duration of our MRI protocol (7, 21). At 
the end of the MRI experiments, 200 µl of plasma “after injection” was obtained. Per 
animal, the total MRI session lasted 1h20min. 
 
Plasma iron concentration determination 
The plasma samples “before injection” and “after injection” were diluted 8 and 20 
times with saline, respectively. T2 measurements were performed on these diluted 
plasma samples using a Carr-Purcell-Meiboom-Gill sequence (400 echoes; echo 
spacing = 0.9 ms and 8 ms for plasma samples collected after and before injection 
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respectively) (22). A mono-exponential decay was fitted to the data to determine T2. 
Plasma iron concentrations were eventually obtained from the measured T2 values 
using [Fe] = 0.01056x(1/T2) - 0.00024 (equation determined in (7)). 
 
Histology 
At the end of the MRI experiment, rats were decapitated. Brains were quickly 
removed, frozen in -40°C isopentane and stored at -80°C and sliced at -20°C with a 
cryostat (20 µm thick sections). 
Vascular structures in brains were detected post-mortem by immunohistochemistry of 
collagen IV. Collagen IV is a constituent of the basal lamina and can thus be used to 
delineate the microvascular contours. Sections were rehydrated in phosphate-
buffered saline (PBS, 0.01M), fixed in 4% paraformaldehyde. After saturation in PBS-
Tween 0.01%-BSA 3% for 1 h at room temperature, a goat antibody directed against 
collagen IV (Southern Biotech, USA) was incubated overnight at 4°C in PBS-Tween 
0.01%-BSA 1% and the revelation was performed using an Alexa 546-linked Donkey 
anti-goat IgG (Invitrogen, France). At the end of the process, slices were 
counterstained with Hoescht 33342. Adjacent sections were stained with 
hematoxylin-eosin (HE) in order to delineate the tumor. 
 
Data Processing 
Region of interest (ROI): Three ROIs (contralateral striatum, contralateral neocortex, 
and tumor) were delineated on the slice (ADC map for MRI and HE section for 
histology) containing the largest tumor area. The ROI "tumor" corresponded to the 
region of increased ADC for the C6 model and to the region of apparently reduced 
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ADC for the RG2 model. Each ROI, delineated on the ADC map, was transferred 
onto the R2, R2*, mVDMRI, DensityMRI, and VSIMRI maps. 
For histological data, the ROI "tumor" corresponded to the region of high cell density 
and was reported on the collagen-IV labeled section. 
Computation of mVDMRI, DensityMRI, and VSIMRI: Changes in transverse relaxation 
rates due to USPIO (R2* and R2) and ADC values were obtained pixelwise as 
previously reported (17). Voxels for which the analysis could not be performed (i.e. 
non converging fit and values outside the range of validity of the method 
(ADC>3000 µm².s-1; R2*≤0;R2≤0)) were marked as excluded. Rejected voxels 
represented 2.5% and 1.9% of the total number of voxels for the C6 and RG2 
models, respectively. For each ROI, mean ADC, R2*, and R2 values were 
computed. Then, mVDMRI was computed as: 
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where ADC was computed as the mean of the ADCs observed in the three principal 
directions of the gradient system; B0 and  represent the static magnetic field and the 
gyromagnetic ratio of the protons. Based on Eq. [13] from (17), the increase in blood 
magnetic susceptibility due to USPIO, , was derived using three different 
approaches: 
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(i)  was considered equal to 0.57 ppm (17). 
(ii) R2* was measured in the contralateral neocortex. In (17), Eq. [3] describes the 
link between  and BVf. This equation may be modified to derive , assuming a 
constant contralateral BVfcontra of 3%: 
0
*
,2
f4
3
BBV
R
contra
contra



 .    [4] 
(iii)  was derived animal per animal from the difference in plasma iron 
concentrations measured before and after injection of USPIO, knowing the saturation 
magnetization of USPIO and the static magnetic field values (17). 
Quantitative histological analysis: Sections (3 slices per animal located around the 
largest size of the tumor mass and 3 microscopic fields per ROI and per slice) were 
digitized using a CCD camera (Olympus, France). The background noise was low 
enough to perform image analysis. Analysis of blood vessels was performed 
automatically using NIH ImageJ software (http://rsb.info.nih.gov/ij/). The photographs 
of blood vessels were binarized by local thresholding at the half-height. Fractional 
vascular surface was computed as the surface occupied by vessels. The vessel 
diameter was derived from the “Morphology-Particles8 plus” plugin. To allow 
comparison between MR and histological estimates, mean vessel diameter 
(mVDhisto), mean vessel density (Densityhisto), fractional vascular surface, and mean 
vessel length were derived. Based on these histological estimates, VSIhisto was 
derived as described in (17). 
 
Propagation of errors 
To evaluate the relative sensitivity of mVDMRI, DensityMRI and VSIMRI to errors, the 
equations for error propagation were derived starting from Eqs [1-3], assuming each 
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contribution independent (Appendix). Errors were evaluated for  25,52 R ms, 
 90,20*2 R  ms, ADC=700 µm²/s and =0.60ppm. The two latter values are the 
mean values found this study and the R2 and R2* ranges correspond to what was 
observed in this study. Note that the procedure was applied on ROIs but could be 
similarly apply on individual pixels. 
 
Statistical analysis 
Paired student t-tests were used for neocortex/striatum and for tumor/striatum 
comparisons. Unpaired student t-tests were used to compare C6 and RG2 tumors. 
The Pearson correlation coefficient was computed to evaluate: 
- whether mVDhisto, Densityhisto, and VSIhisto obtained on all ROIs and all animals are 
predictors of mVDMRI, DensityMRI, and VSIMRI, respectively; 
- which estimate of  yields the best correlation between VSIhisto and VSIMRI. 
All results are expressed as mean ± SD. 
The effects of time and tumor model were evaluated with an ANOVA, using 
Bonferroni correction for multiple comparisons, for each MRI microvascular estimates 
(mVDMRI, DensityMRI, and VSIMRI). 
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Results 
Impact of  and ADC on VSIMRI estimates 
The three approaches used to compute  yielded the following correlations between 
VSIMRI and VSIhisto: R²=0.70 for the constant ; R²=0.74 for the  obtained 
considering a constant contralateral BVf and R²=0.73 for the  obtained from 
estimated USPIO concentration in each animal (p<0.001 in all cases; data not 
shown). This result is in line with a variable  across injections (cf. Table 1), due to 
inter-animal or inter-species variability and to limited accuracy on the injected 
volume. To remain consistent with previously published results (7),  measured 
animal by animal was used in the subsequent analysis. We also observed that using 
a constant ADC in Eq. [3] (like in (17), where ADC=700 µm2.s-1 was used) instead of 
the measured ADC reduces the R² from 0.73 to 0.71 (p<0.001). Using both a 
constant ADC and a constant  led to R²=0.64 (p<0.001). 
Mean estimates of mVD, Density and VSI 
Figure 1 shows examples of MRI maps and histological field of views of one 
representative animal of each model. Table 1 shows the estimates derived from MRI 
and from histology for the three ROIs in Wistar and Fischer rats (averaged across all 
animals in each case). Striatum and neocortex yield similar estimates for both MRI 
and histology (except in Wistar rats for whom the Densityhisto was 14% lower in the 
striatum than in the neocortex). For both MRI and histology, the standard deviation in 
non-tumoral ROIs (an estimate of the reproducibility) was better than 20%, except for 
DensityMRI for which the standard deviation increases up to 50% (31% on average). 
As the tumor evolves over time, the standard deviation measured in the tumor is 
larger than in the contralateral tissue. Estimates obtained in the tumor ROIs were 
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different from those obtained in the striatum (except for ADC in the RG2 model). Both 
tumors exhibited larger vessel diameters (higher VSI and mVD) and lower Density 
than the contralateral striatum. All MRI and histological estimates were able to 
differentiate C6 from RG2, except mVDMRI. 
Errors on mVDMRI, DensityMRI and VSIMRI 
As Eqs. [1-3] are a mixture of additions, products, and powers, the relative errors on 
mVDMRI, DensityMRI, and VSIMRI are constants if the relative errors on R2, R2*, 
ADC,  are also constant. Setting the relative errors on R2 and R2* to 10 and 
15% (reproducibility observed in the laboratory) and the relative errors on ADC and 
 to 0 led to an error on mVDMRI=18.0%, DensityMRI=49.2% and VSIMRI=27.0%. 
Note that for errors on mVDMRI and VSIMRI, the relative contributions of the errors on 
R2 and R2* are equivalent. This is not the case for DensityMRI for which the 
contribution of the error on R2 is 1.5 that of the error on R2*. If the relative error on 
R2 is only 10%, then the relative error on DensityMRI becomes 36.1%. For VSI, two 
additional parameters are used: ADC and . When the relative errors on ADC and 
 are set to 10% instead of 0, the relative error on VSIMRI becomes 27.9%. 
MRI versus histology 
Figure 2 shows the correlation between the three MRI estimates and their 
corresponding histological estimates for all ROIs and all animals (data from both 
tumor models were pooled). A positive correlation is obtained for the three 
microvascular characteristics studied in vivo and ex vivo: mVD (Fig. 2a), Density (Fig. 
2b), and VSI (Fig. 2c). The lowest correlation between MRI and histology is obtained 
for Density (R²=0.50, p<0.001). The correlation between mVDMRI and mVDhisto is 
better (R²=0.62, p<0.001) and the best correlation is found between VSIMRI and 
VSIhisto (R²=0.73, p<0.001). One also found a very good correlation between mVD 
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and VSI (R²=0.79 between MRI estimates; R²=0.76 between histological estimates; 
data not shown; p<0.001 in both cases). Bland-Altman graphs (Fig. 3) reveal a slight 
bias between MRI and histology for all estimates (26% for mVD; 13% for Density; -
15% for VSI). Note that for mVD, the bias is computed between an amount computed 
in arbitrary unit (mVDMRI) and an amount expressed in µm (mVDhisto) and as such 
may not be interpreted as the bias obtained for Density and VSI. A trend appears for 
VSI: MRI overestimates histology as VSI increases. In all cases, more than 90% of 
the data are within the range mean ± 2 standard-deviations, however. 
Temporal evolution of microvascular characteristics 
Figure 4 shows the temporal evolution of mVDMRI, DensityMRI, and VSIMRI in C6 and 
RG2 tumors and in the contralateral striatum. In the striatum, these three estimates 
appear robust (low SD), except for DensityMRI in the Wistar rats which exhibits higher 
SD. From a statistical point of view (Table 2), no time and no model effect was 
observed for the striatum, except for VSIMRI which differs between Wistar and Fischer 
rats. In both tumor types, mVDMRI and VSIMRI increases as tumor evolves, while 
DensityMRI decreases. In the tumor, a time and a model effects are observed for the 
three MRI estimates, except for mVDMRI whose evolution is comparable between the 
two models. 
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Discussion 
In this study, three MRI estimates derived from the changes in R2 and R2* 
consecutive to the injection of USPIO are compared to their histological counterparts 
using data collected on rats bearing orthotopic C6 and RG2 gliomas. A positive 
correlation was found between in vivo and ex vivo measurements of the three 
metrics. Our results indicate that MRI mapping of the mVD, Density, and VSI may be 
used to characterize tumor angiogenesis well beyond BVf.  
Both tumors exhibited the same evolution pattern: an increase in vessel diameter 
associated to a decrease in vessel density. This evolution pattern does not imply a 
change in BVf. In (7), it was shown that BVf remains stable over time for the C6 
model while it increases for the RG2 model. Thus, one should be cautious when 
using BVf as sole characteristic of angiogenesis. 
 
Microvascular estimates obtained in normal brain (averaged across neocortex and 
striatum and across all animals) are in good agreement with previously reported 
values. Dennie et al. reported a mVDMRI of 4.8±0.3 a.u. in the rat brain (11), while we 
observed 3.7±0.6 a.u. Wu et al. reported a DensityMRI of 282±43 vessel.mm
-2 in the 
mouse brain (13), while we observed 271 ± 83 vessel.mm-2. Tropres et al. reported a 
VSIMRI of 4.5±0.8 µm in the rat brain (17), while we observed 4.2±0.9 µm. Regarding 
error propagation, one can notice that the variabilities obtained in this study for 
mVDMRI, DensityMRI, and VSIMRI (16%, 31%, and 21% respectively) are lower than the 
errors obtained from the propagation analysis (18.0%, 49.2%, and 27.9% 
respectively), suggesting a possible mechanism of error compensation during data 
processing. 
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Numerous factors may bias histological and MRI measurements. First, histological 
estimates are based on the analysis of all vessels while MRI estimates rely on 
vessels perfused by the contrast agent. In histology, freezing may induce a tissue 
expansion, cryosectioning a tissue compression (23) and measuring the external 
diameter of objects stained with a pan-vascular marker like Collagen IV may yield an 
overestimation of the vessel diameter. The stereological extrapolation of surface to 
volume parameters has limited accuracy because of the underlying assumption that 
vessels are perfect cylinders. Also, a 20 µm-thick histological slice does not 
accurately represent a 1 mm-thick MRI slice across a heterogeneous tumor. MRI 
estimates may be biased by the difference between the spatial configuration of real 
vessels (especially in a tumor) in the voxels used in this study and the idealized 
configuration (perfect cylinders, large number of vessels, voxel size) used in 
modeling (24, 25) or by macroscopic magnetic field heterogeneities. In the present 
study, none of the quantitative data available – alone or combined – may explain the 
differences in absolute values observed in Figure 3. Further studies are needed for a 
finer validation of the MRI measurements, including numerical simulations to evaluate 
the impact of the assumptions of the model (such as voxel size, oxygen saturation, 
microvascular organization, presence of myelin...). 
 
The lower correlation between MRI and histology values obtained for Density could 
be ascribed in part to the lower accuracy on DensityMRI obtained in this study. This 
lower accuracy arises from the noise level which was higher on R2 than on R2* 
and from the fact that DensityMRI is more sensitive to the noise on R2 than to the 
noise on R2* while mVD and VSI are similarly sensitive to the noise on R2 and on 
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R2*. Despite this lower accuracy on DensityMRI, similar bias between MRI and 
histology were found for Density and VSI (less than 15% in both cases). From a 
correlation point of view, the better correlation coefficient obtained between MRI and 
histological estimates of VSI compared to those obtained for mVD and Density could 
be ascribed in part to the more careful quantification performed in Eq. [3]: the 
computation of VSI includes the estimate of ADC (which varies between tumor and 
contralateral tissue) and of the actual contrast agent concentration (which has a 
variability above 24% in this study) while mVD and Density do not. Indeed, using a 
constant ADC and a constant contrast agent concentration reduces the correlation 
coefficient between MRI and histological estimates of VSI down to R²=0.64, close to 
the value found for MRI and histological estimates of mVD (R²=0.62) or between 
VSIMRI and mVDHisto (R²=0.62). One can also observe that the additional error due to 
the use of ADC and  is small (0.9% difference in error propagations). In case the 
actual contrast agent concentration may not readily be obtained (e.g. in a clinical 
setting), an estimate of the local contrast agent concentration obtained by 
considering a constant blood volume fraction in the contralateral region appears as a 
very good solution (similar correlations between MRI and histology estimates of VSI 
are obtained when using a measured and a  estimated from the contralateral 
BVf). 
 
In conclusion, this study indicates that MRI and histological estimates of mVD, 
Density, and VSI obtained on the same animals are well correlated and may be used 
to characterize angiogenesis in vivo beyond BVf. While the results obtained in this 
study were obtained using a USPIO and a steady-state approach, it has recently 
been shown that a dynamic approach using Gd-chelate yielded similar results to 
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those obtained with USPIO at steady-state (19, 26). A combination of blood volume 
fraction, Density, and VSI or mVD (the latter two are well correlated) appears thus 
desirable to improve the characterization of angiogenesis in patients.  
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Appendix 
 
The error on mVD, mVD , is given by: 
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The error on Density, Density , is given by: 
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The error on VSI, VSI , is given by: 
 
        2
2
2
2
2*
2
2
*
2
2
2
2
2
2
)( 

 












VSI
ADC
ADC
VSI
R
R
VSI
R
R
VSI
VSI  [A7] 
 
where ADC  and   are the errors on ADC and  estimates, respectively, and with  
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Figure captions 
Figure 1. MRI and histological images obtained from one representative animal of 
each model: (a) C6 and (b) RG2. The three ROIs used in this study are overlaid on 
the T2-weighted images (blue: tumor, green: cortex and red: striatum). Excluded 
pixels are displayed in yellow. 
 
Figure 2. Correlation between MRI and histological estimates of (a) mVD, (b) 
Density, and (c) VSI. A point corresponds to one ROI (contralateral striatum, 
contralateral neocortex or tumor) in one animal. 
 
Figure 3. Bland-Altman plots comparing histological and MRI estimates of (a) mVD, 
(b) Density, and (c) VSI. A point corresponds to one ROI (contralateral striatum, 
contralateral neocortex or tumor) in one animal. The thick line corresponds to the 
mean difference between MRI and histological estimates and the thin dotted lines to 
two standard deviations. 
 
Figure 4. Temporal evolution of mVD (a, b), Density (c, d), and VSI (e, f) for tumor 
(filled circles) and contralateral striatum (open squares) ROIs (average across 
animals).  
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Table 1.  derived from change in iron plasma concentration for Wistar and Fisher rats, averaged across animals. MRI estimates 
(ADC, mVDMRI, DensityMRI, VSIMRI), and histological estimates (mVDhisto, Densityhisto, VSIhisto) within the neocortex, the striatum, and 
the tumor of Wistar and Fischer rats. * p<0.05 between striatum and neocortex; $$ p<0.01 and $$$ p<0.001 between tumor and 
striatum; £ p<0.05, ££ p<0.01 and £££ p<0.001 between C6 and RG2 tumors.  
 
 
 Wistar Rats (C6 model) Fischer Rats (RG2 model)  
 (ppm) 0.50 ± 0.15 0.71 ± 0.17 
 
 Neocortex Striatum Tumor Neocortex Striatum Tumor 
 
ADC (µm².s-1) 724 ± 39 733 ± 40 919 ± 74$$$ 675 ± 29 679 ± 32 651 ± 63£££ 
 
mVDMRI (a.u.) 3.5 ± 0.5 3.8 ± 0.8 5.9 ± 1.3
$$$ 3.7 ± 0.7 3.8 ± 0.4 5.4 ± 1.6$$ 
 
DensityMRI (vessel. mm
-2) 294 ± 48 240 ± 115 79 ± 62$$$ 300 ± 92 251 ± 34 159 ± 79$$,££ 
 
VSIMRI (µm) 4.4 ± 0.7 4.9 ± 1.1 10.9 ± 4.2
$$$ 3.7 ± 0.8 3.8 ± 0.5 6.6 ± 2.7$$,££ 
 
 
 
mVDhisto (µm) 4.8 ± 0.3 4.8 ± 0.3 8.1 ± 1.0
$$$ 5.2 ± 0.3 5.3 ± 0.4 6.8 ± 1.5$$,££ 
 
Densityhisto (vessel.mm
-2) 343 ± 36 295 ± 61* 80 ± 26$$$ 322 ± 22 303 ± 42 200 ± 59$$$,£££ 
 
VSIhisto (µm) 3.8 ± 0.2 4.0 ± 0.5 7.9 ± 2.1
$$$ 4.0 ± 0.3 4.0 ± 0.3 6.1 ± 1.6$$,£ 
 
 
1 
 
Table 2. Statistical evaluation of the effects of time and glioma model (C6 or RG2) on mVDMRI, DensityMRI, VSIMRI 
 
 
 mVDMRI DensityMRI VSIMRI 
 __________________________ __________________________ __________________________ 
 time model time x model time model time x model time model time x model 
 
Striatum ns ns ns ns ns ns ns p=0.02 ns 
 
Tumor p<0.001 ns ns p<0.001 p<0.001 p=0.07 p<0.001 p<0.001 ns 
 
